173 related articles for article (PubMed ID: 22397719)
21. T-cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease.
Tötterman TH; Carlsson M; Simonsson B; Bengtsson M; Nilsson K
Blood; 1989 Aug; 74(2):786-92. PubMed ID: 2787679
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of T-cell-associated antigens on B-cell non-Hodgkin lymphomas.
Kaleem Z; White G; Zutter MM
Am J Clin Pathol; 2001 Mar; 115(3):396-403. PubMed ID: 11242796
[TBL] [Abstract][Full Text] [Related]
23. Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age.
Rea IM; Stewart M; Campbell P; Alexander HD; Crockard AD; Morris TC
Gerontology; 1996; 42(2):69-78. PubMed ID: 9138976
[TBL] [Abstract][Full Text] [Related]
24. Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia.
Kater AP; Remmerswaal EB; Nolte MA; Eldering E; van Oers MH; van Lier RA
Br J Haematol; 2004 Aug; 126(4):512-6. PubMed ID: 15287944
[TBL] [Abstract][Full Text] [Related]
25. Age dependency and mutual relations in T and B lymphocyte abnormalities in common variable immunodeficiency patients.
Vlková M; Thon V; Sárfyová M; Bláha L; Svobodník A; Lokaj J; Litzman J
Clin Exp Immunol; 2006 Feb; 143(2):373-9. PubMed ID: 16412063
[TBL] [Abstract][Full Text] [Related]
26. CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients.
Borge M; Nannini PR; Morande PE; Jancic C; Bistmans A; Bezares RF; Giordano M; Gamberale R
Cancer Immunol Immunother; 2013 Jan; 62(1):113-24. PubMed ID: 22842611
[TBL] [Abstract][Full Text] [Related]
27. CD45RO+ T-cells immunoregulate spontaneous in vitro immunoglobulin production by normal and chronic lymphocytic leukaemia B-cells.
Frolova EA; Scott SC; Jones RA
Leuk Lymphoma; 1995 Jun; 18(1-2):103-11. PubMed ID: 8580811
[TBL] [Abstract][Full Text] [Related]
28. Programmed death-1 and its ligand are novel immunotolerant molecules expressed on leukemic B cells in chronic lymphocytic leukemia.
Grzywnowicz M; Zaleska J; Mertens D; Tomczak W; Wlasiuk P; Kosior K; Piechnik A; Bojarska-Junak A; Dmoszynska A; Giannopoulos K
PLoS One; 2012; 7(4):e35178. PubMed ID: 22532845
[TBL] [Abstract][Full Text] [Related]
29. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
30. Difference in the relative distribution of CD4+ T-cell subsets in B-CLL with mutated and unmutated immunoglobulin (Ig) VH genes: implication for the course of disease.
Tinhofer I; Weiss L; Gassner F; Rubenzer G; Holler C; Greil R
J Immunother; 2009 Apr; 32(3):302-9. PubMed ID: 19242370
[TBL] [Abstract][Full Text] [Related]
31. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL).
Frolova EA; Richards SJ; Jones RA; Rawstron A; Master PS; Teasdale J; Short M; Jack AS; Scott CS
Leuk Lymphoma; 1995 Jan; 16(3-4):307-18. PubMed ID: 7719238
[TBL] [Abstract][Full Text] [Related]
32. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
[TBL] [Abstract][Full Text] [Related]
33. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
[TBL] [Abstract][Full Text] [Related]
34. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis.
Martinez A; Pittaluga S; Villamor N; Colomer D; Rozman M; Raffeld M; Montserrat E; Campo E; Jaffe ES
Am J Surg Pathol; 2004 Jul; 28(7):849-58. PubMed ID: 15223953
[TBL] [Abstract][Full Text] [Related]
35. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
[TBL] [Abstract][Full Text] [Related]
36. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
37. Correlation of cytomegalovirus and human herpesvirus 7 with CD3+ and CD3+ CD4+ cells in chronic periodontitis patients.
Thomasini RL; Bonon SH; Durante P; Costa SC
J Periodontal Res; 2012 Feb; 47(1):114-20. PubMed ID: 21895663
[TBL] [Abstract][Full Text] [Related]
38. Chronic lymphocytic leukemia specific T-cell subset alterations are clone-size dependent and not present in monoclonal B lymphocytosis.
te Raa GD; Tonino SH; Remmerswaal EB; van Houte AJ; Koene HR; van Oers MH; Kater AP
Leuk Lymphoma; 2012 Nov; 53(11):2321-5. PubMed ID: 22646856
[TBL] [Abstract][Full Text] [Related]
39. Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.
Kay NE; Han L; Bone N; Williams G
Br J Haematol; 2001 Mar; 112(3):760-7. PubMed ID: 11260081
[TBL] [Abstract][Full Text] [Related]
40. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
